/u/WalkingHorse's posts

Year:

Only show posts with narrations

Liquid biopsy and 18F-FDG PET/CT derived parameters as predictive factors of osimertinib treatment in advanced EGFR-mutated NSCLC

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

LISTEN>>> Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer - Lung Cancer Update Podcast

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

PD-L1 Expression Remains Primary Guide for NSCLC Treatment Selection in the Absence of Targetable Mutations

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

Participants Discuss Rare Dual Immunotherapy AE Experiences in NSCLC

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

Study Suggests Need for New Second-Line NSCLC Therapies to Follow Osimertinib

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

Liquid Biopsy May Be Helpful for Treatment Decisions in ROS1-Positive NSCLC

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

WATCH>>> Dr Bazhenova on Improving Biomarker Development in Lung Cancer

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

PD-L1 Expression Remains Primary Guide for NSCLC Treatment Selection in the Absence of Targetable Mutations

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

Effects of brain radiotherapy strategies on survival in the era of MRI for patients with limited stage small cell lung cancer | BMC Cancer

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

Current status and factors influencing the work readiness of middle-aged and young postoperative lung cancer patients

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

Title	Upvotes	Subreddit	Mark as read	Favorited	Rating	Add to a list
Liquid biopsy and 18F-FDG PET/CT derived parameters as predictive factors of osimertinib treatment in advanced EGFR-mutated NSCLC	1	LungCancerSupport
LISTEN>>> Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer - Lung Cancer Update Podcast	1	LungCancerSupport
PD-L1 Expression Remains Primary Guide for NSCLC Treatment Selection in the Absence of Targetable Mutations	1	LungCancerSupport
Participants Discuss Rare Dual Immunotherapy AE Experiences in NSCLC	1	LungCancerSupport
Study Suggests Need for New Second-Line NSCLC Therapies to Follow Osimertinib	1	LungCancerSupport
Liquid Biopsy May Be Helpful for Treatment Decisions in ROS1-Positive NSCLC	1	LungCancerSupport
WATCH>>> Dr Bazhenova on Improving Biomarker Development in Lung Cancer	1	LungCancerSupport
PD-L1 Expression Remains Primary Guide for NSCLC Treatment Selection in the Absence of Targetable Mutations	1	LungCancerSupport
Effects of brain radiotherapy strategies on survival in the era of MRI for patients with limited stage small cell lung cancer \| BMC Cancer	1	LungCancerSupport
Current status and factors influencing the work readiness of middle-aged and young postoperative lung cancer patients	1	LungCancerSupport